Global 23-valent Pneumococcal Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “23-valent Pneumococcal Vaccine Industry Forecast” looks at past sales and reviews total world 23-valent Pneumococcal Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected 23-valent Pneumococcal Vaccine sales for 2023 through 2029. With 23-valent Pneumococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 23-valent Pneumococcal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 23-valent Pneumococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 23-valent Pneumococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global 23-valent Pneumococcal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 23-valent Pneumococcal Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 23-valent Pneumococcal Vaccine.
The global 23-valent Pneumococcal Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for 23-valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for 23-valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for 23-valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key 23-valent Pneumococcal Vaccine players cover Merck, Sanofipasteur, CDIBP, Kexing Bio, Changsheng Bio-Technology and Huaan Science and Technology Innovation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-valent Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global 23-valent Pneumococcal Vaccine market?
What factors are driving 23-valent Pneumococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 23-valent Pneumococcal Vaccine market opportunities vary by end market size?
How does 23-valent Pneumococcal Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “23-valent Pneumococcal Vaccine Industry Forecast” looks at past sales and reviews total world 23-valent Pneumococcal Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected 23-valent Pneumococcal Vaccine sales for 2023 through 2029. With 23-valent Pneumococcal Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 23-valent Pneumococcal Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 23-valent Pneumococcal Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 23-valent Pneumococcal Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global 23-valent Pneumococcal Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 23-valent Pneumococcal Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 23-valent Pneumococcal Vaccine.
The global 23-valent Pneumococcal Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for 23-valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for 23-valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for 23-valent Pneumococcal Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key 23-valent Pneumococcal Vaccine players cover Merck, Sanofipasteur, CDIBP, Kexing Bio, Changsheng Bio-Technology and Huaan Science and Technology Innovation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-valent Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Single Dose Vial
- Pre-filled Syringe
- Chronic Cardiovascular Disease
- Chronic Lung Disease
- Chronic Liver Disease
- People Living with Hiv
- Leukemia
- Lymphoma
- Multiple Myeloma
- General Malignancy
- Chronic Kidney Disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Sanofipasteur
- CDIBP
- Kexing Bio
- Changsheng Bio-Technology
- Huaan Science and Technology Innovation
What is the 10-year outlook for the global 23-valent Pneumococcal Vaccine market?
What factors are driving 23-valent Pneumococcal Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 23-valent Pneumococcal Vaccine market opportunities vary by end market size?
How does 23-valent Pneumococcal Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Country/Region, 2018, 2022 & 2029
2.2 23-valent Pneumococcal Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-valent Pneumococcal Vaccine Sales by Type
2.3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Type (2018-2023)
2.4 23-valent Pneumococcal Vaccine Segment by Application
2.4.1 Chronic Cardiovascular Disease
2.4.2 Chronic Lung Disease
2.4.3 Chronic Liver Disease
2.4.4 People Living with Hiv
2.4.5 Leukemia
2.4.6 Lymphoma
2.4.7 Multiple Myeloma
2.4.8 General Malignancy
2.4.9 Chronic Kidney Disease
2.4.10 Other
2.5 23-valent Pneumococcal Vaccine Sales by Application
2.5.1 Global 23-valent Pneumococcal Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global 23-valent Pneumococcal Vaccine Sale Price by Application (2018-2023)
3 GLOBAL 23-VALENT PNEUMOCOCCAL VACCINE BY COMPANY
3.1 Global 23-valent Pneumococcal Vaccine Breakdown Data by Company
3.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2018-2023)
3.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global 23-valent Pneumococcal Vaccine Revenue by Company (2018-2023)
3.2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-valent Pneumococcal Vaccine Product Location Distribution
3.4.2 Players 23-valent Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR 23-VALENT PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 23-valent Pneumococcal Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic 23-valent Pneumococcal Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas 23-valent Pneumococcal Vaccine Sales Growth
4.4 APAC 23-valent Pneumococcal Vaccine Sales Growth
4.5 Europe 23-valent Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas 23-valent Pneumococcal Vaccine Sales by Country
5.1.1 Americas 23-valent Pneumococcal Vaccine Sales by Country (2018-2023)
5.1.2 Americas 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023)
5.2 Americas 23-valent Pneumococcal Vaccine Sales by Type
5.3 Americas 23-valent Pneumococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-valent Pneumococcal Vaccine Sales by Region
6.1.1 APAC 23-valent Pneumococcal Vaccine Sales by Region (2018-2023)
6.1.2 APAC 23-valent Pneumococcal Vaccine Revenue by Region (2018-2023)
6.2 APAC 23-valent Pneumococcal Vaccine Sales by Type
6.3 APAC 23-valent Pneumococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 23-valent Pneumococcal Vaccine by Country
7.1.1 Europe 23-valent Pneumococcal Vaccine Sales by Country (2018-2023)
7.1.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023)
7.2 Europe 23-valent Pneumococcal Vaccine Sales by Type
7.3 Europe 23-valent Pneumococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 23-valent Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
10.4 Industry Chain Structure of 23-valent Pneumococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-valent Pneumococcal Vaccine Distributors
11.3 23-valent Pneumococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR 23-VALENT PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global 23-valent Pneumococcal Vaccine Market Size Forecast by Region
12.1.1 Global 23-valent Pneumococcal Vaccine Forecast by Region (2024-2029)
12.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-valent Pneumococcal Vaccine Forecast by Type
12.7 Global 23-valent Pneumococcal Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofipasteur
13.2.1 Sanofipasteur Company Information
13.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofipasteur Main Business Overview
13.2.5 Sanofipasteur Latest Developments
13.3 CDIBP
13.3.1 CDIBP Company Information
13.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CDIBP Main Business Overview
13.3.5 CDIBP Latest Developments
13.4 Kexing Bio
13.4.1 Kexing Bio Company Information
13.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kexing Bio Main Business Overview
13.4.5 Kexing Bio Latest Developments
13.5 Changsheng Bio-Technology
13.5.1 Changsheng Bio-Technology Company Information
13.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Changsheng Bio-Technology Main Business Overview
13.5.5 Changsheng Bio-Technology Latest Developments
13.6 Huaan Science and Technology Innovation
13.6.1 Huaan Science and Technology Innovation Company Information
13.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Huaan Science and Technology Innovation Main Business Overview
13.6.5 Huaan Science and Technology Innovation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Country/Region, 2018, 2022 & 2029
2.2 23-valent Pneumococcal Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-valent Pneumococcal Vaccine Sales by Type
2.3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Type (2018-2023)
2.4 23-valent Pneumococcal Vaccine Segment by Application
2.4.1 Chronic Cardiovascular Disease
2.4.2 Chronic Lung Disease
2.4.3 Chronic Liver Disease
2.4.4 People Living with Hiv
2.4.5 Leukemia
2.4.6 Lymphoma
2.4.7 Multiple Myeloma
2.4.8 General Malignancy
2.4.9 Chronic Kidney Disease
2.4.10 Other
2.5 23-valent Pneumococcal Vaccine Sales by Application
2.5.1 Global 23-valent Pneumococcal Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global 23-valent Pneumococcal Vaccine Sale Price by Application (2018-2023)
3 GLOBAL 23-VALENT PNEUMOCOCCAL VACCINE BY COMPANY
3.1 Global 23-valent Pneumococcal Vaccine Breakdown Data by Company
3.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2018-2023)
3.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global 23-valent Pneumococcal Vaccine Revenue by Company (2018-2023)
3.2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Company
3.4 Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-valent Pneumococcal Vaccine Product Location Distribution
3.4.2 Players 23-valent Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR 23-VALENT PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 23-valent Pneumococcal Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic 23-valent Pneumococcal Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas 23-valent Pneumococcal Vaccine Sales Growth
4.4 APAC 23-valent Pneumococcal Vaccine Sales Growth
4.5 Europe 23-valent Pneumococcal Vaccine Sales Growth
4.6 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Growth
5 AMERICAS
5.1 Americas 23-valent Pneumococcal Vaccine Sales by Country
5.1.1 Americas 23-valent Pneumococcal Vaccine Sales by Country (2018-2023)
5.1.2 Americas 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023)
5.2 Americas 23-valent Pneumococcal Vaccine Sales by Type
5.3 Americas 23-valent Pneumococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-valent Pneumococcal Vaccine Sales by Region
6.1.1 APAC 23-valent Pneumococcal Vaccine Sales by Region (2018-2023)
6.1.2 APAC 23-valent Pneumococcal Vaccine Revenue by Region (2018-2023)
6.2 APAC 23-valent Pneumococcal Vaccine Sales by Type
6.3 APAC 23-valent Pneumococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 23-valent Pneumococcal Vaccine by Country
7.1.1 Europe 23-valent Pneumococcal Vaccine Sales by Country (2018-2023)
7.1.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023)
7.2 Europe 23-valent Pneumococcal Vaccine Sales by Type
7.3 Europe 23-valent Pneumococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 23-valent Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine
10.3 Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
10.4 Industry Chain Structure of 23-valent Pneumococcal Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-valent Pneumococcal Vaccine Distributors
11.3 23-valent Pneumococcal Vaccine Customer
12 WORLD FORECAST REVIEW FOR 23-VALENT PNEUMOCOCCAL VACCINE BY GEOGRAPHIC REGION
12.1 Global 23-valent Pneumococcal Vaccine Market Size Forecast by Region
12.1.1 Global 23-valent Pneumococcal Vaccine Forecast by Region (2024-2029)
12.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-valent Pneumococcal Vaccine Forecast by Type
12.7 Global 23-valent Pneumococcal Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofipasteur
13.2.1 Sanofipasteur Company Information
13.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofipasteur Main Business Overview
13.2.5 Sanofipasteur Latest Developments
13.3 CDIBP
13.3.1 CDIBP Company Information
13.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CDIBP Main Business Overview
13.3.5 CDIBP Latest Developments
13.4 Kexing Bio
13.4.1 Kexing Bio Company Information
13.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kexing Bio Main Business Overview
13.4.5 Kexing Bio Latest Developments
13.5 Changsheng Bio-Technology
13.5.1 Changsheng Bio-Technology Company Information
13.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Changsheng Bio-Technology Main Business Overview
13.5.5 Changsheng Bio-Technology Latest Developments
13.6 Huaan Science and Technology Innovation
13.6.1 Huaan Science and Technology Innovation Company Information
13.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
13.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Huaan Science and Technology Innovation Main Business Overview
13.6.5 Huaan Science and Technology Innovation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global 23-valent Pneumococcal Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global 23-valent Pneumococcal Vaccine Revenue by Application (2018-2023)
Table 13. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global 23-valent Pneumococcal Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global 23-valent Pneumococcal Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-valent Pneumococcal Vaccine Products Offered
Table 22. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-valent Pneumococcal Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global 23-valent Pneumococcal Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global 23-valent Pneumococcal Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global 23-valent Pneumococcal Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global 23-valent Pneumococcal Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global 23-valent Pneumococcal Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas 23-valent Pneumococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC 23-valent Pneumococcal Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe 23-valent Pneumococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of 23-valent Pneumococcal Vaccine
Table 58. Key Market Challenges & Risks of 23-valent Pneumococcal Vaccine
Table 59. Key Industry Trends of 23-valent Pneumococcal Vaccine
Table 60. 23-valent Pneumococcal Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. 23-valent Pneumococcal Vaccine Distributors List
Table 63. 23-valent Pneumococcal Vaccine Customer List
Table 64. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 80. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofipasteur 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 85. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sanofipasteur Main Business
Table 87. Sanofipasteur Latest Developments
Table 88. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. CDIBP 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 90. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. CDIBP Main Business
Table 92. CDIBP Latest Developments
Table 93. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Kexing Bio 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 95. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Kexing Bio Main Business
Table 97. Kexing Bio Latest Developments
Table 98. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 100. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Changsheng Bio-Technology Main Business
Table 102. Changsheng Bio-Technology Latest Developments
Table 103. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 105. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Huaan Science and Technology Innovation Main Business
Table 107. Huaan Science and Technology Innovation Latest Developments
Table 1. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global 23-valent Pneumococcal Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global 23-valent Pneumococcal Vaccine Revenue by Application (2018-2023)
Table 13. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global 23-valent Pneumococcal Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global 23-valent Pneumococcal Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-valent Pneumococcal Vaccine Products Offered
Table 22. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-valent Pneumococcal Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global 23-valent Pneumococcal Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global 23-valent Pneumococcal Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global 23-valent Pneumococcal Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global 23-valent Pneumococcal Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global 23-valent Pneumococcal Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas 23-valent Pneumococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC 23-valent Pneumococcal Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe 23-valent Pneumococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of 23-valent Pneumococcal Vaccine
Table 58. Key Market Challenges & Risks of 23-valent Pneumococcal Vaccine
Table 59. Key Industry Trends of 23-valent Pneumococcal Vaccine
Table 60. 23-valent Pneumococcal Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. 23-valent Pneumococcal Vaccine Distributors List
Table 63. 23-valent Pneumococcal Vaccine Customer List
Table 64. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 80. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofipasteur 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 85. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sanofipasteur Main Business
Table 87. Sanofipasteur Latest Developments
Table 88. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. CDIBP 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 90. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. CDIBP Main Business
Table 92. CDIBP Latest Developments
Table 93. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Kexing Bio 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 95. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Kexing Bio Main Business
Table 97. Kexing Bio Latest Developments
Table 98. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 100. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Changsheng Bio-Technology Main Business
Table 102. Changsheng Bio-Technology Latest Developments
Table 103. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Portfolios and Specifications
Table 105. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Huaan Science and Technology Innovation Main Business
Table 107. Huaan Science and Technology Innovation Latest Developments
LIST OF FIGURES
Figure 1. Picture of 23-valent Pneumococcal Vaccine
Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2022
Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease
Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2018-2023) & (K Units)
Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease
Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2018-2023) & (K Units)
Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease
Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2018-2023) & (K Units)
Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv
Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2018-2023) & (K Units)
Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia
Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2018-2023) & (K Units)
Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma
Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2018-2023) & (K Units)
Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma
Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2018-2023) & (K Units)
Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy
Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2018-2023) & (K Units)
Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease
Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2018-2023) & (K Units)
Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other
Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2018-2023) & (K Units)
Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2022)
Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2022
Figure 35. 23-valent Pneumococcal Vaccine Sales Market by Company in 2022 (K Units)
Figure 36. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company in 2022
Figure 37. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2022
Figure 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 40. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2022
Figure 41. Americas 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 42. Americas 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 43. APAC 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 44. APAC 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 45. Europe 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 46. Europe 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 47. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 48. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2022
Figure 50. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2022
Figure 51. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 52. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 53. United States 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2022
Figure 58. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2022
Figure 59. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 60. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 61. China 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. South Korea 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. India 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. China Taiwan 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2022
Figure 69. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2022
Figure 70. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 71. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 72. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. France 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. UK 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 77. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2022
Figure 78. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2022
Figure 79. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 80. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 81. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 82. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 83. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 84. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 85. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 86. Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine in 2022
Figure 87. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
Figure 88. Industry Chain Structure of 23-valent Pneumococcal Vaccine
Figure 89. Channels of Distribution
Figure 90. Global 23-valent Pneumococcal Vaccine Sales Market Forecast by Region (2024-2029)
Figure 91. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 92. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 93. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 94. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 95. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of 23-valent Pneumococcal Vaccine
Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2022
Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease
Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2018-2023) & (K Units)
Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease
Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2018-2023) & (K Units)
Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease
Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2018-2023) & (K Units)
Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv
Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2018-2023) & (K Units)
Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia
Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2018-2023) & (K Units)
Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma
Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2018-2023) & (K Units)
Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma
Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2018-2023) & (K Units)
Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy
Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2018-2023) & (K Units)
Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease
Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2018-2023) & (K Units)
Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other
Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2018-2023) & (K Units)
Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2022)
Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2022
Figure 35. 23-valent Pneumococcal Vaccine Sales Market by Company in 2022 (K Units)
Figure 36. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company in 2022
Figure 37. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2022
Figure 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 40. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2022
Figure 41. Americas 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 42. Americas 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 43. APAC 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 44. APAC 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 45. Europe 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 46. Europe 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 47. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2018-2023 (K Units)
Figure 48. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2018-2023 ($ Millions)
Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2022
Figure 50. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2022
Figure 51. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 52. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 53. United States 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2022
Figure 58. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2022
Figure 59. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 60. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 61. China 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. South Korea 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. India 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. China Taiwan 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2022
Figure 69. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2022
Figure 70. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 71. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 72. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. France 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. UK 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 77. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2022
Figure 78. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2022
Figure 79. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Figure 80. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2018-2023)
Figure 81. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 82. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 83. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 84. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 85. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 86. Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine in 2022
Figure 87. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
Figure 88. Industry Chain Structure of 23-valent Pneumococcal Vaccine
Figure 89. Channels of Distribution
Figure 90. Global 23-valent Pneumococcal Vaccine Sales Market Forecast by Region (2024-2029)
Figure 91. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 92. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 93. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 94. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 95. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2024-2029)
